Kennedy Capital Management »

Prelude Therapeutics shares owned by Kennedy Capital Management

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Kennedy Capital Management from 13F filings

Historical chart of Kennedy Capital Management investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Kennedy Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $134k 35k 3.81
2024-03-31 $119k 25k 4.74